VitaDX

medical devices

About

VitaDX is a French deep tech startup that specializes in developing and commercializing innovative cancer diagnostic solutions. Founded in April 2015 and headquartered in Rennes and Paris, the company employs around 20 professionals, including developers, data scientists, and biologists. The flagship product, VisioCyt® Bladder, is an in vitro diagnostic medical device designed for the early detection of bladder cancer using a simple urine sample. This solution utilizes patented fluorescence imaging technology and AI algorithms to analyze cytological samples, enabling non-invasive diagnosis. VisioCyt® Bladder has received CE IVDR marking and has been available for prescription since late 2022 or early 2023 through partnerships with anatomopathology laboratories. VitaDX is committed to providing efficient and reliable cancer diagnostic tools and collaborates with various hospitals and testing laboratories. The company is also pursuing regulatory approval in the United States and exploring the adaptation of its technology for the early detection of other cancers.

Technologies

Outlook Microsoft Office 365 Amazon AWS Nginx Google Analytics Google Tag Manager YouTube Mobile Friendly Bootstrap Framework IoT AI

Keywords

diagnostic bladder cancer software analysis fluorescence artificial intelligence deep learning machine learning image processing diagnostic medical device ai image analysis in oncology biotechnology healthcare innovation medical devices non-invasive bladder cancer test healthcare equipment & supplies clinical validation diagnostic solutions ce ivdr cytology image recognition bladder cancer surveillance patient monitoring cancer diagnostics cancer detection ai diagnostics patient care healthcare technology in vitro diagnostic medical imaging medical diagnostics

Location

28 Rue de Chambery, Paris, Ile-de-France, France, 75015

Related Companies

Companies in the same industry